1-8 of 8
Sonya J. Snedecor
Close
Sort by
Journal Articles

Protective Effects of HbF on Mortality in Sickle Cell Disease

Olga Mitelman, Jonathan Barry, Jonathan Bernhard, Paul Bruno, Sonya J. Snedecor, Sarah Ronnebaum, Geoffrey A. Allen, Christopher Morabito
Journal: Blood
Blood (2022) 140 (Supplement 1): 11118–11119.
https://doi.org/10.1182/blood-2022-158284
Published: 2022
Journal Articles

Efficacy Outcomes of Treatments for Double Relapsed/Refractory Follicular Lymphoma (R/R FL): A Systematic Literature Review

Brad S. Kahl, MD, Anik R. Patel, PhD, Omer Zaidi, Sonya J. Snedecor, PhD, Anna G. Purdum, PharmD,MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-136228
Published: 2020
Journal Articles

Efficacy of Systemic Therapies for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (R/R iNHL): A Systematic Literature Review (SLR)

Emmanuel Bachy, MD PhD, Christopher P. Fox, MD PhD, Luca Arcaini, MD, Francisco J. Hernandez-Ilizaliturri, MD, Susannah Howlett, Sonya J. Snedecor, Jacob Franek, Omer Zaidi, Ashley Tabah
Journal: Blood
Blood (2018) 132 (Supplement 1): 2266.
https://doi.org/10.1182/blood-2018-99-112892
Published: 2018
Journal Articles

Attainment of Complete Remission Is Significantly Associated with Longer Survival Outcomes in Relapsed/Refractory (R/R) CLL: A Meta-Analysis

Varun Ektare, MPH, Christopher P. Fox, MBChB, PhD, Rod S Taylor, MSc, PhD, Inocencio J Timothy, PharmD, PhD, German E Pena, MD, Johnathan C Maher, PhD, Sonya J. Snedecor, PhD
Journal: Blood
Blood (2016) 128 (22): 2045.
https://doi.org/10.1182/blood.V128.22.2045.2045
Published: 2016
Journal Articles

Increased Eligibility for Attempting Treatment-Free Remission (TFR) with Frontline Nilotinib (NIL) vs Imatinib (IM) in Patients with Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia (CML): Results of a Stochastic Simulation Model

Francois-Xavier Mahon, MD PhD Professor, An Tran-Duy, Raechelle G. Ocampo, David Ray, PharmD, MBA, Estella Mendelson, BSRN, MBA, Aby Buchbinder, Pascal Edrich, Sonya J. Snedecor, PhD, Giuseppe Saglio
Journal: Blood
Blood (2015) 126 (23): 5154.
https://doi.org/10.1182/blood.V126.23.5154.5154
Published: 2015
Journal Articles

Early Molecular Response (EMR) with Frontline Treatment Is a Significant Predictor of Long-Term BCR-ABL Transcript Levels in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML) in Chronic Phase

Giuseppe Saglio, Sonya J. Snedecor, PhD, Xiang Ji, Ming-Hui Tai, BPharm, MHPA, PhD, David Ray, PharmD, MBA, Estella Mendelson, BSRN, MBA, Aby Buchbinder, Pascal Edrich, Francois-Xavier Mahon, MD PhD Professor
Journal: Blood
Blood (2015) 126 (23): 1579.
https://doi.org/10.1182/blood.V126.23.1579.1579
Published: 2015
Journal Articles

Front-Line, Dose-Escalated Immunochemotherapy Is Associated with a Significant PFS (but not OS) Advantage in 401 Patients (Pts) with Double-Hit Lymphomas (DHL): A Systematic Review and Meta-Analysis

Christina Howlett, PharmD, BCOP, Daniel J. Landsburg, MD, Elise A. Chong, MD, Sonya J Snedecor, PhD, Stephen J. Schuster, MD, Tina Marie Green, MD, Jonathon B. Cohen, MD, Jakub Svoboda, MD, Sunita Dwivedy Nasta, MD, Tatyana Feldman, MD, Allison Rago, BSN, Danielle Land, CRNP, Kristy M. Walsh, BS, Andre Goy, MD, Anthony R. Mato, MD MSCE
Journal: Blood
Blood (2014) 124 (21): 3056.
https://doi.org/10.1182/blood.V124.21.3056.3056
Published: 2014
Journal Articles

Estimating Long-Term Life Expectancy in Philadelphia Chromosome Positive (Ph+) Chronic Phase Chronic Myeloid Leukemia (CML-CP): Results of A Microsimulation Model

Sonya J Snedecor, PhD, Xiang Ji, MS, Matthew Magestro, Andrew M Stein, PhD, Marc Botteman, MSc, MA
Journal: Blood
Blood (2012) 120 (21): 4441.
https://doi.org/10.1182/blood.V120.21.4441.4441
Published: 2012